tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Leland Gershell, 227 are a BUY (94.58%), 5 are a SELL (2.08%), 8 are a HOLD (3.33%).
Analyst Leland Gershell, currently employed at OPPENHEIMER, carries an average stock price target met ratio of 49.04% that have a potential upside of 46.72% achieved within 193 days.
Leland Gershell’s has documented 483 price targets and ratings displayed on 53 stocks. The coverage is on the Healthcare sector.
Most recent stock forecast was given on CAPR, Capricor Therapeutics at 08-Dec-2025.
Analyst best performing recommendations are on AVTX (AVALO THERAPEUTICS).
The best stock recommendation documented was for AVTX (AVALO THERAPEUTICS) at 8/8/2022. The price target of $1200 was fulfilled within 1 day with a profit of $259.2 (27.55%) receiving and performance score of 275.51.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 12-Jul-2023
$12
$8.63 (256.08%)
$12
1 years 4 months 16 days ago
(26-Sep-2024)
0/2 (0%)
$8.93 (290.88%)
Buy
$2.5
$-0.28 (-10.07%)
2 years 11 months 27 days ago
(15-Feb-2023)
1/1 (100%)
$1.86 (290.63%)
145
Buy Since 15-Feb-2022
$30
3 years 7 months 20 days ago
(22-Jun-2022)
0/1 (0%)
$22.32 (290.63%)
Hold Since 02-Sep-2020
$12
$8.63 (256.08%)
$144
5 years 5 months 9 days ago
(02-Sep-2020)
1/2 (50%)
$1.58 (15.16%)
19
Buy Since 31-Aug-2020
5 years 5 months 11 days ago
(31-Aug-2020)
0/1 (0%)
$59.52 (163.16%)
Which stock is Leland Gershell is most bullish on?
Which stock is Leland Gershell is most reserved on?
What Year was the first public recommendation made by Leland Gershell?
